Charles A. Deignan - 20 Dec 2022 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Chief Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
20 Dec 2022
Net transactions value
+$9,454
Form type
4
Filing time
20 Dec 2022, 15:38:43 UTC
Previous filing
28 Jan 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $9,454 +23,636 +6.7% $0.4000 377,502 20 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Options Exercise $0 -23,636 -100% $0.000000* 0 20 Dec 2022 Common Stock 23,636 $0.4000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.